EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fifty years of the mitochondrial pyruvate carrier: New insights into its structure, function, and inhibition

Sotiria Tavoulari iD, Maximilian Sichrovsky iD, Edmund R S Kunji iD

Acta Physiologica · 2023-08 · 238 (4)

DOI: 10.1111/apha.14016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Physiologica, online erschienen am 27.06.2023. Verfasst von Sotiria Tavoulari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Mitochondrial Membrane Transport Proteins. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mitochondrial pyruvate carrier (MPC) resides in the mitochondrial inner membrane, where it links cytosolic and mitochondrial metabolism by transporting pyruvate produced in glycolysis into the mitochondrial matrix. Due to its central metabolic role, it has been proposed as a potential drug target for diabetes, non‐alcoholic fatty liver disease, neurodegeneration, and cancers relying on mitochondrial metabolism. Little is known about the structure and mechanism of MPC, as the proteins involved were only identified a decade ago and technical difficulties concerning their purification and stability have hindered progress in functional and structural analyses. The functional unit of MPC is a hetero‐dimer comprising two small homologous membrane proteins, MPC1/MPC2 in humans, with the alternative complex MPC1L/MPC2 forming in the testis, but MPC proteins are found throughout the tree of life. The predicted topology of each protomer consists of an amphipathic helix followed by three transmembrane helices. An increasing number of inhibitors are being identified, expanding MPC pharmacology and providing insights into the inhibitory mechanism. Here, we provide critical insights on the composition, structure, and function of the complex and we summarize the different classes of small molecule inhibitors and their potential in therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monocarboxylic Acid TransportersMitochondrial Membrane Transport ProteinsMaleHumansMitochondriaMitochondrial MembranesMitochondrial ProteinsPyruvic Acid

Stichwörter der Autor:innen

metabolismmitochondriapyruvate transportsmall molecule inhibitorstransport mechanism

Substanzen

Monocarboxylic Acid TransportersMitochondrial Membrane Transport ProteinsMitochondrial ProteinsPyruvic Acid

Autor:innen und Institutionen

  • Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.

ORCID-Profile: Sotiria Tavoulari, Maximilian Sichrovsky, Edmund R S Kunji

Förderung

  • Medical Research Council

Zitieren

APA

Tavoulari, S., Sichrovsky, M., & Kunji, E. R. S. (2023). Fifty years of the mitochondrial pyruvate carrier: New insights into its structure, function, and inhibition. Acta Physiologica, 238(4). https://doi.org/10.1111/apha.14016

Vancouver

Tavoulari S, Sichrovsky M, Kunji ERS. Fifty years of the mitochondrial pyruvate carrier: New insights into its structure, function, and inhibition. Acta Physiologica. 2023;238(4). doi:10.1111/apha.14016

BibTeX
@article{Tavoulari2023,
  author = {Tavoulari, Sotiria and Sichrovsky, Maximilian and Kunji, Edmund R S},
  title = {Fifty years of the mitochondrial pyruvate carrier: New insights into its structure, function, and inhibition},
  journal = {Acta Physiologica},
  year = {2023},
  volume = {238},
  number = {4},
  doi = {10.1111/apha.14016}
}
Kostenlos starten →